30 results
10-K
2024 FY
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
2018 to November 2023. With extensive experience in global leadership, Peter was the Regional Chief Executive Officer for Australasia and Greater
S-1/A
IXHL
Incannex Healthcare Limited
17 Jul 24
IPO registration (amended)
8:47am
senior leadership positions in academic and clinical psychiatry and has published more than 150 scientific articles, books, book chapters, and conference … development assets for Incannex. Prior to his appointment as Chief Executive Officer, Mr. Latham had been a key member of our senior leadership team
S-1
IXHL
Incannex Healthcare Limited
3 Jul 24
IPO registration
6:29am
and New Zealand College of Psychiatrists and a consultant psychiatrist. He holds senior leadership positions in academic and clinical psychiatry … Executive Officer, Mr. Latham had been a key member of our senior leadership team acting as General Manager since 2016. During this time, he
8-K
EX-99.1
IXHL
Incannex Healthcare Limited
16 Apr 24
Incannex Healthcare Inc. Quarterly Update, Q1 2024
9:30am
been strong with over 500 potential patients expressing an interest in treatment to date. Clarion has assembled a world class clinical leadership team
8-K
EX-99.1
IXHL
Incannex Healthcare Limited
1 Feb 24
Other Events
7:30am
@incannex.com.au
Page 1 | 3
Date: February 1, 2024
Public Announcement (NASDAQ: IXHL)
“Our clinical, support, and leadership teams at Clarion
8-K
EX-14.1
ziw0anwg t7zt2vkj
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
6-K
EX-99.1
i94gq2n38
1 Sep 23
Report of Foreign Private Issuer
12:00am
6-K
EX-99.1
1aqhzz5z0wu 5qu2ukh
8 Aug 23
Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening
6:02am
6-K
EX-99.1
d8wvygexabn
13 Jul 23
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
6:02am
6-K
EX-99.1
sbj6skhyrnpwqmr
18 May 23
Report of Foreign Private Issuer
8:00am
6-K
EX-99.1
6d4p77b6vuoyif60
26 Apr 23
Incannex Healthcare March 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
9:40pm
20-F
pfoajfl981
28 Oct 22
Annual report (foreign)
6:31am
6-K
EX-99.1
f05tum0s5td a4sewpz8
21 Oct 22
Report of Foreign Private Issuer
6:08am
6-K
EX-99.1
oe19m1as
19 Sep 22
Report of Foreign Private Issuer
9:38pm
6-K
EX-99.1
bkck9fuuu5vqnij
17 Aug 22
Incannex Appoints FDA Regulatory Affairs Expert Mr Robert B. Clark to the Board of Directors
6:04am
6-K
EX-99.1
5xw7y2kw3k
9 Aug 22
Report of Foreign Private Issuer
6:01am
6-K
EX-99.3
gsyev 22y2sqbpeza1
12 May 22
Report of Foreign Private Issuer
9:25am
20FR12B/A
ylwm0yttn7z h87dm
24 Feb 22
Initial registration of securities (foreign private issuers) (amended)
3:42pm
20FR12B/A
6m439l 0n
22 Feb 22
Initial registration of securities (foreign private issuers) (amended)
6:10am